Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
12/2006
12/07/2006CA2609552A1 Molecular glue
12/07/2006CA2609543A1 Mutant il-10
12/07/2006CA2609262A1 Anti-cd14 antibody fusion protein
12/07/2006CA2609226A1 Coagulation factor x polypeptides with modified activation properties
12/07/2006CA2609221A1 A peptide ligand to impair cancer cell migration
12/07/2006CA2609060A1 Production of recombinant il-18 binding protein
12/07/2006CA2599322A1 N protein mutants of porcine reproductive and respiratory syndrome virus
12/06/2006EP1729135A2 Methods for differentiating and monitoring parathyroid and bone status related diseases
12/06/2006EP1728870A2 Transcription factor stress-related proteins and methods of use in plants
12/06/2006EP1728869A2 Gene expression construct of hap1 adapted for plant cells
12/06/2006EP1728868A2 Herbicide resistant plants
12/06/2006EP1728865A1 Treatment of cervical cancer
12/06/2006EP1728864A1 Monoclonal antibodies specific for different epitopes of human gp39 and methods for their use in diagnosis and therapy
12/06/2006EP1728800A1 Papilloma virus-like particles, fusion proteins and process for producing the same
12/06/2006EP1728799A1 Human kinase interacting protein 2 (KIP2)-related gene variant (KIP2V1) associated with prostate cancer
12/06/2006EP1728798A1 Coagulation factor X polypeptides with modified activation properties
12/06/2006EP1728516A1 A method for inhibition of phospholamban activity for the treatment of cardiac disease and heart failure
12/06/2006EP1728441A2 Plants which synthesise a modified starch, process for the production thereof and modified starch
12/06/2006EP1728424A2 Method to treat conditions associated with insulin signaling dysregulation
12/06/2006EP1728077A2 Method for determination and quantification of radiation or genotoxin exposure
12/06/2006EP1727915A2 Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof
12/06/2006EP1727912A2 Human obesity susceptibility genes encoding peptide hormones and uses thereof
12/06/2006EP1727904A1 Peptide-based method for monitoring gene expression in a host cell
12/06/2006EP1727901A2 Materials and methods for treatment of cancer
12/06/2006EP1727899A2 Method
12/06/2006EP1727833A1 Recombinant polypeptides of the members of the tnf ligand family and use thereof
12/06/2006EP1727832A2 Antigen of the pm-2 antibody and use thereof
12/06/2006EP1727831A1 Genes and polypeptides relating to prostate cancers
12/06/2006EP1727830A1 Mussel bioadhesive
12/06/2006EP1727829A1 Hypha-specific cell wall proteins of candida
12/06/2006EP1727828A1 Compositions of polypeptides specific to pathogenic strains and their use as vaccines and in immunotherapy
12/06/2006EP1727827A1 Library of toxin mutants, and methods of using same
12/06/2006EP1727826A2 Lactobacillus acidophilus nucleic acid sequences encoding carbohydrate utilization-related proteins and uses therefor
12/06/2006EP1727560A2 Gastrointestinal proliferative factor and uses thereof
12/06/2006EP1727546A2 Methods and formulations for protecting cells, and for treating diseases and conditions by optimizing the intracellular concentration of nad
12/06/2006EP1727423A1 Preparation of recombinant rotavirus proteins in milk of transgenic non-human mammals
12/06/2006EP1682571A4 A bidentate motif and methods of use
12/06/2006EP1682570A4 A binding motif and methods of regulating cell function
12/06/2006EP1638598B1 ACAPSULAR i P. MULTOCIDA HYAE /i DELETION MUTANTS
12/06/2006EP1629106A4 METHODS OF INDUCING THE EXPRESSION OF BONE MORPHOGENETIC PROTEINS (BMPs) AND TRANSFORMING GROWTH FACTOR-beta-PROTEINS (TGF-betas) IN CELLS
12/06/2006EP1572954A4 Npc1l1 (npc3) and methods of use thereof
12/06/2006EP1456222A4 Non-human primate fc receptors and methods of use
12/06/2006EP1430304B1 Method for diagnosing chronic inflammatory bowel diseases
12/06/2006EP1385887A4 Repressors for hiv transcription and methods thereof
12/06/2006EP1353688B1 Method and compositions for immunization with the pseudomonas v antigen
12/06/2006EP1295612B1 Use of a treating solution for inactivating prions
12/06/2006EP1144661B1 Method of genetic modification of a wild type viral sequence
12/06/2006EP1117685B1 Treatment of inflammatory disease
12/06/2006EP1114830B1 Cerebral organic anion transporter and its gene
12/06/2006EP1097171B1 Method for purifying hemoglobin
12/06/2006EP1078001B1 Il-6 antagonist peptides
12/06/2006EP1054971B1 Group b streptococcus antigens
12/06/2006EP1025226B1 Dna encoding a human proton-gated ion channel and uses thereof
12/06/2006EP1007686B1 Tuberculosis vaccine
12/06/2006EP0969865B1 Mhc class ii antigen-presenting systems and methods for activating cd4?+ t cells
12/06/2006EP0938503B1 Insulin c-peptides
12/06/2006EP0912749B1 Suppression of specific classes of soybean seed protein genes
12/06/2006EP0910406B1 Recombinant canine herpesviruses
12/06/2006EP0837934B1 Human vascular endothelial growth factor 2
12/06/2006EP0820598B1 Assaying protein fragments in body fluids
12/06/2006EP0740701B1 Mammalian monocyte chemoattractant protein receptors
12/06/2006EP0717107B1 Transformant line of candida utilis yeast and expression of heterogene therewith
12/06/2006EP0688362B1 Cloning and recombinant production of vespid venom enzymes, such as phospholipase and hyaluronidase, and immunological therapies based thereon
12/06/2006CN1875110A Process for producing lactic acid bacerium culture containing bacteriocin and method of storing food using the same
12/06/2006CN1875107A Vectors
12/06/2006CN1875104A Anti-angiogenic peptides from the N-terminus of endostatin
12/06/2006CN1875100A BACE455, an alternative splice variant of the human beta-secretase
12/06/2006CN1875098A Carbohydrate-binding modules of a new family
12/06/2006CN1875097A Hybrid enzymes
12/06/2006CN1875033A High troughput functional assay for G-protein coupled receptors using a RAP-RAS chimeric protein
12/06/2006CN1875029A Expression in filamentous fungi of protease inhibitors and variants thereof
12/06/2006CN1875028A Seneca valley virus based compositions and methods for treating disease
12/06/2006CN1874787A Composition for the prophylaxis/treatment of HBV infections and HBV-mediated diseases
12/06/2006CN1874783A Agent against malignant neuroglia and agent against malignant neuroglia for animals
12/06/2006CN1874782A RAGE-related methods and compositions for treating glomerular injury
12/06/2006CN1873013A Recombinant adenoviral vector and methods of use
12/06/2006CN1873008A Gene promoters
12/06/2006CN1873006A Method for producing recombined human proinsulin
12/06/2006CN1873005A Conjugated protein Tau of microtubule of earthworm, its coding gene, and application
12/06/2006CN1873003A 真菌细胞壁合成基因 Fungal cell wall synthesis genes
12/06/2006CN1873002A 真菌细胞壁合成基因 Fungal cell wall synthesis genes
12/06/2006CN1872994A 感染性克隆 Infectious clone
12/06/2006CN1872881A Long effective amalgamation protein of erythropoietin of human, preparing and purifying methods
12/06/2006CN1872879A Anagonism active polypeptide of CXCR4 acceptor from inflammation protein of virus macrophage
12/06/2006CN1872878A Jingzhao toxin V
12/06/2006CN1872877A Idiosyncratic antigen protein, and antigen peptide of liver cancer orchis pellet
12/06/2006CN1872876A Transcription factor of DREB class in cotton, its coding gene, and application
12/06/2006CN1872875A Anti-viral protein of ash tree flower, method of extraction, and application
12/06/2006CN1872874A Method for preparing capsid protein ú¿VPú®of enteric cytopathogenic human orphan virus 30
12/06/2006CN1872333A Placenta factor, preparation method and application
12/06/2006CN1288247C ARCELIN-5 promoter and use thereof
12/06/2006CN1288166C Modified tumor antigen peptide and use thereof
12/06/2006CN1288165C A preparation derived from shark cartilage for treatment of diseases related to excessive PHF or excessive intracellular calcium
12/06/2006CN1287861C Human source gene guide sequence, gene carrier and gene expression method
12/06/2006CN1287853C Treatment of follicular lymphomas using inhibitors of the lymphotoxin (LT) pathway
12/05/2006US7145019 Biotinated macromolecules having protein reactive groups that react with functional groups on proteins including sulfhydryl and amine groups, used in the detection and isolation of targets from heterologous mixtures
12/05/2006US7144998 for preparing antigens or antigen fragments of Clostridum toxins; use in immunogenic and/or vaccine compositions
12/05/2006US7144997 Vertebrate embryonic patterning-inducing proteins, compositions and uses related therto
12/05/2006US7144996 Nucleic acid encoding human suppressor of fused
12/05/2006US7144992 Synergistic antimicrobial compositions and methods for reducing biofilm formation